-
1
-
-
85008512074
-
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency
-
Abolhassani, H., E.S.J. Edwards, A. Ikinciogullari, H. Jing, S. Borte, M. Buggert, L. Du, M. Matsuda-Lennikov, R. Romano, R. Caridha, et al. 2017. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J. Exp. Med. 214:91-106. http://dx.doi.org/10.1084/jem.20160849
-
(2017)
J. Exp. Med
, vol.214
, pp. 91-106
-
-
Abolhassani, H.1
Edwards, E.S.J.2
Ikinciogullari, A.3
Jing, H.4
Borte, S.5
Buggert, M.6
Du, L.7
Matsuda-Lennikov, M.8
Romano, R.9
Caridha, R.10
-
2
-
-
84929840480
-
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome
-
Aguilar, C., and S. Latour. 2015. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome. J. Clin. Immunol. 35:331-338. http://dx.doi.org/10.1007/s10875-015-0141-9
-
(2015)
J. Clin. Immunol
, vol.35
, pp. 331-338
-
-
Aguilar, C.1
Latour, S.2
-
3
-
-
84941188919
-
Novel mutations in TNF RSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency
-
Alkhairy, O.K., R. Perez-Becker, G.J. Driessen, H. Abolhassani, J. van Montfrans, S. Borte, S. Choo, N. Wang, K. Tesselaar, M. Fang, et al. 2015. Novel mutations in TNF RSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. J. Allergy Clin. Immunol. 136:703-712.e10. http://dx.doi.org/10.1016/j.jaci.2015.02.022
-
(2015)
J. Allergy Clin. Immunol
, vol.136
, pp. 703.e10-712.e10
-
-
Alkhairy, O.K.1
Perez-Becker, R.2
Driessen, G.J.3
Abolhassani, H.4
van Montfrans, J.5
Borte, S.6
Choo, S.7
Wang, N.8
Tesselaar, K.9
Fang, M.10
-
4
-
-
0141449970
-
Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection
-
Amyes, E., C. Hatton, D. Montamat-Sicotte, N. Gudgeon, A.B. Rickinson, A.J. McMichael, and M.F. Callan. 2003. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J. Exp. Med. 198:903-911. http://dx.doi.org/10.1084/jem.20022058
-
(2003)
J. Exp. Med
, vol.198
, pp. 903-911
-
-
Amyes, E.1
Hatton, C.2
Montamat-Sicotte, D.3
Gudgeon, N.4
Rickinson, A.B.5
McMichael, A.J.6
Callan, M.F.7
-
5
-
-
84908147824
-
Role for early-differentiated natural killer cells in infectious mononucleosis
-
Azzi, T., A. Lünemann, A. Murer, S. Ueda, V. Béziat, K.J. Malmberg, G. Staubli, C. Gysin, C. Berger, C. Münz, et al. 2014. Role for early-differentiated natural killer cells in infectious mononucleosis. Blood. 124:2533-2543. http://dx.doi.org/10.1182/blood-2014-01-553024
-
(2014)
Blood
, vol.124
, pp. 2533-2543
-
-
Azzi, T.1
Lünemann, A.2
Murer, A.3
Ueda, S.4
Béziat, V.5
Malmberg, K.J.6
Staubli, G.7
Gysin, C.8
Berger, C.9
Münz, C.10
-
6
-
-
84872981290
-
Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students
-
Balfour, H.H. Jr., O.A. Odumade, D.O. Schmeling, B.D. Mullan, J.A. Ed, J.A. Knight, H.E. Vezina, W. Thomas, and K.A. Hogquist. 2013. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J. Infect. Dis. 207:80-88. http://dx.doi.org/10.1093/infdis/jis646
-
(2013)
J. Infect. Dis
, vol.207
, pp. 80-88
-
-
Balfour, H.H.1
Odumade, O.A.2
Schmeling, D.O.3
Mullan, B.D.4
Ed, J.A.5
Knight, J.A.6
Vezina, H.E.7
Thomas, W.8
Hogquist, K.A.9
-
7
-
-
0016391672
-
Fatal infectious mononucleosis in a family
-
Bar, R.S., C.J. DeLor, K.P. Clausen, P. Hurtubise, W. Henle, and J.F. Hewetson. 1974. Fatal infectious mononucleosis in a family. N. Engl. J. Med. 290:363-367. http://dx.doi.org/10.1056/NEJM197402142900704
-
(1974)
N. Engl. J. Med
, vol.290
, pp. 363-367
-
-
Bar, R.S.1
DeLor, C.J.2
Clausen, K.P.3
Hurtubise, P.4
Henle, W.5
Hewetson, J.F.6
-
8
-
-
84943358637
-
High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency
-
Bienemann, K., A. Borkhardt, W. Klapper, and I. Oschlies. 2015. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency. Histopathology. 67:607-616. http://dx.doi.org/10.1111/his.12677
-
(2015)
Histopathology
, vol.67
, pp. 607-616
-
-
Bienemann, K.1
Borkhardt, A.2
Klapper, W.3
Oschlies, I.4
-
9
-
-
84977277258
-
T cells for viral infections after allogeneic hematopoietic stem cell transplant
-
Bollard, C.M., and H.E. Heslop. 2016. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood. 127:3331-3340. http://dx.doi.org/10.1182/blood-2016-01-628982
-
(2016)
Blood
, vol.127
, pp. 3331-3340
-
-
Bollard, C.M.1
Heslop, H.E.2
-
10
-
-
84898647949
-
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins
-
Bollard, C.M., S. Gottschalk, V. Torrano, O. Diouf, S. Ku, Y. Hazrat, G. Carrum, C. Ramos, L. Fayad, E.J. Shpall, et al. 2014. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J. Clin. Oncol. 32:798-808. http://dx.doi.org/10.1200/JCO.2013.51.5304
-
(2014)
J. Clin. Oncol
, vol.32
, pp. 798-808
-
-
Bollard, C.M.1
Gottschalk, S.2
Torrano, V.3
Diouf, O.4
Ku, S.5
Hazrat, Y.6
Carrum, G.7
Ramos, C.8
Fayad, L.9
Shpall, E.J.10
-
11
-
-
78650984696
-
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease
-
Booth, C., K.C. Gilmour, P. Veys, A.R. Gennery, M.A. Slatter, H. Chapel, P.T. Heath, C.G. Steward, O. Smith, A. O'Meara, et al. 2011. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 117:53-62. http://dx.doi.org/10.1182/blood-2010-06-284935
-
(2011)
Blood
, vol.117
, pp. 53-62
-
-
Booth, C.1
Gilmour, K.C.2
Veys, P.3
Gennery, A.R.4
Slatter, M.A.5
Chapel, H.6
Heath, P.T.7
Steward, C.G.8
Smith, O.9
O'Meara, A.10
-
12
-
-
18844364782
-
CD27 and CD70 in T cell and B cell activation
-
Borst, J., J. Hendriks, and Y. Xiao. 2005. CD27 and CD70 in T cell and B cell activation. Curr. Opin. Immunol. 17:275-281. http://dx.doi.org/10.1016/j.coi.2005.04.004
-
(2005)
Curr. Opin. Immunol
, vol.17
, pp. 275-281
-
-
Borst, J.1
Hendriks, J.2
Xiao, Y.3
-
13
-
-
0035817326
-
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease
-
Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L.D. Notarangelo, L. Moretta, and A. Moretta. 2001. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:235-246. http://dx.doi.org/10.1084/jem.194.3.235
-
(2001)
J. Exp. Med
, vol.194
, pp. 235-246
-
-
Bottino, C.1
Falco, M.2
Parolini, S.3
Marcenaro, E.4
Augugliaro, R.5
Sivori, S.6
Landi, E.7
Biassoni, R.8
Notarangelo, L.D.9
Moretta, L.10
Moretta, A.11
-
14
-
-
84976332661
-
NF-κB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation
-
Boztug, H., T. Hirschmugl, W. Holter, K. Lakatos, L. Kager, D. Trapin, W. Pickl, E. Förster-Waldl, and K. Boztug. 2016. NF-κB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation. J. Clin. Immunol. 36:533-540. http://dx.doi.org/10.1007/s10875-016-0306-1
-
(2016)
J. Clin. Immunol
, vol.36
, pp. 533-540
-
-
Boztug, H.1
Hirschmugl, T.2
Holter, W.3
Lakatos, K.4
Kager, L.5
Trapin, D.6
Pickl, W.7
Förster-Waldl, E.8
Boztug, K.9
-
15
-
-
84872943896
-
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
-
Brennan, P.J., M. Brigl, and M.B. Brenner. 2013. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13:101-117. http://dx.doi.org/10.1038/nri3369
-
(2013)
Nat. Rev. Immunol
, vol.13
, pp. 101-117
-
-
Brennan, P.J.1
Brigl, M.2
Brenner, M.B.3
-
16
-
-
85012274630
-
Large deletion of MAGT1 gene in a patient with classic kaposi sarcoma, CD4 lymphopenia, and EBV infection
-
Brigida, I., M. Chiriaco, S. Di Cesare, D. Cittaro, G. Di Matteo, S. Giannelli, D. Lazarevic, M. Zoccolillo, E. Stupka, A. Jenkner, et al. 2016. Large deletion of MAGT1 gene in a patient with classic kaposi sarcoma, CD4 lymphopenia, and EBV infection. J. Clin. Immunol. 1:1-2.
-
(2016)
J. Clin. Immunol
, vol.1
, pp. 1-2
-
-
Brigida, I.1
Chiriaco, M.2
Di Cesare, S.3
Cittaro, D.4
Di Matteo, G.5
Giannelli, S.6
Lazarevic, D.7
Zoccolillo, M.8
Stupka, E.9
Jenkner, A.10
-
17
-
-
84979645718
-
Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other
-
çagdas, D., B. Erman, D. Hanoglu, B. Tavil, B. Kuskonmaz, B. Aydin, C. Akyüz, D. Uçkan, ö. Sanal, and I. Tezcan. 2017. Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other. Bone Marrow Transplant. 52:126-129. http://dx.doi.org/10.1038/bmt.2016.185
-
(2017)
Bone Marrow Transplant
, vol.52
, pp. 126-129
-
-
Çagdas, D.1
Erman, B.2
Hanoglu, D.3
Tavil, B.4
Kuskonmaz, B.5
Aydin, B.6
Akyüz, C.7
Uçkan, D.8
Sanal, Ö.9
Tezcan, I.10
-
18
-
-
0033693309
-
+ T-cell selection, function, and death in the primary immune response in vivo
-
+ T-cell selection, function, and death in the primary immune response in vivo. J. Clin. Invest. 106:1251-1261. http://dx.doi.org/10.1172/JCI10590
-
(2000)
J. Clin. Invest
, vol.106
, pp. 1251-1261
-
-
Callan, M.F.1
Fazou, C.2
Yang, H.3
Rostron, T.4
Poon, K.5
Hatton, C.6
McMichael, A.J.7
-
19
-
-
84880283279
-
2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D
-
2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 341:186-191. http://dx.doi.org/10.1126/science.1240094
-
(2013)
Science
, vol.341
, pp. 186-191
-
-
Chaigne-Delalande, B.1
Li, F.Y.2
O'Connor, G.M.3
Lukacs, M.J.4
Jiang, P.5
Zheng, L.6
Shatzer, A.7
Biancalana, M.8
Pittaluga, S.9
Matthews, H.F.10
-
20
-
-
0034733682
-
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
-
Chan, F.K., H.J. Chun, L. Zheng, R.M. Siegel, K.L. Bui, and M.J. Lenardo. 2000. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science. 288:2351-2354. http://dx.doi.org/10.1126/science.288.5475.2351
-
(2000)
Science
, vol.288
, pp. 2351-2354
-
-
Chan, F.K.1
Chun, H.J.2
Zheng, L.3
Siegel, R.M.4
Bui, K.L.5
Lenardo, M.J.6
-
21
-
-
84890973428
-
Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection
-
Chijioke, O., A. Müller, R. Feederle, M.H.M. Barros, C. Krieg, V. Emmel, E. Marcenaro, C.S. Leung, O. Antsiferova, V. Landtwing, et al. 2013. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Reports. 5:1489-1498. http://dx.doi.org/10.1016/j.celrep.2013.11.041
-
(2013)
Cell Reports
, vol.5
, pp. 1489-1498
-
-
Chijioke, O.1
Müller, A.2
Feederle, R.3
Barros, M.H.M.4
Krieg, C.5
Emmel, V.6
Marcenaro, E.7
Leung, C.S.8
Antsiferova, O.9
Landtwing, V.10
-
22
-
-
84989283935
-
NK cell influence on the outcome of primary Epstein-Barr virus infection
-
Chijioke, O., V. Landtwing, and C. Münz. 2016. NK cell influence on the outcome of primary Epstein-Barr virus infection. Front. Immunol. 7:323. http://dx.doi.org/10.3389/fimmu.2016.00323
-
(2016)
Front. Immunol
, vol.7
, pp. 323
-
-
Chijioke, O.1
Landtwing, V.2
Münz, C.3
-
23
-
-
84891550264
-
Innate immune control of EBV-infected B cells by invariant natural killer T cells
-
Chung, B.K., K. Tsai, L.L. Allan, D.J. Zheng, J.C. Nie, C.M. Biggs, M.R. Hasan, F.K. Kozak, P. van den Elzen, J.J. Priatel, and R. Tan. 2013. Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood. 122:2600-2608. http://dx.doi.org/10.1182/blood-2013-01-480665
-
(2013)
Blood
, vol.122
, pp. 2600-2608
-
-
Chung, B.K.1
Tsai, K.2
Allan, L.L.3
Zheng, D.J.4
Nie, J.C.5
Biggs, C.M.6
Hasan, M.R.7
Kozak, F.K.8
van den Elzen, P.9
Priatel, J.J.10
Tan, R.11
-
24
-
-
84945259598
-
ITK deficiency: How can EBV be treated before lymphoma?
-
Cipe, F.E., C. Aydogmus, N.K. Serwas, D. Tugcu, M. Demirkaya, F.A. Biçici, A.B. Hocaoglu, F. Dogu, and K. Boztug. 2015. ITK deficiency: How can EBV be treated before lymphoma? Pediatr. Blood Cancer. 62:2247-2248. http://dx.doi.org/10.1002/pbc.25648
-
(2015)
Pediatr. Blood Cancer
, vol.62
, pp. 2247-2248
-
-
Cipe, F.E.1
Aydogmus, C.2
Serwas, N.K.3
Tugcu, D.4
Demirkaya, M.5
Biçici, F.A.6
Hocaoglu, A.B.7
Dogu, F.8
Boztug, K.9
-
25
-
-
17344372694
-
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
-
Coffey, A.J., R.A. Brooksbank, O. Brandau, T. Oohashi, G.R. Howell, J.M. Bye, A.P. Cahn, J. Durham, P. Heath, P. Wray, et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:129-135. http://dx.doi.org/10.1038/2424
-
(1998)
Nat. Genet
, vol.20
, pp. 129-135
-
-
Coffey, A.J.1
Brooksbank, R.A.2
Brandau, O.3
Oohashi, T.4
Howell, G.R.5
Bye, J.M.6
Cahn, A.P.7
Durham, J.8
Heath, P.9
Wray, P.10
-
26
-
-
85083544825
-
Epstein-barr virus vaccines
-
Cohen, J.I. 2015a. Epstein-barr virus vaccines. Clin. Transl. Immunology. 4:e32. http://dx.doi.org/10.1038/cti.2014.27
-
(2015)
Clin. Transl. Immunology
, vol.4
-
-
Cohen, J.I.1
-
27
-
-
84942909324
-
Primary immunodeficiencies associated with EBV disease
-
Cohen, J.I. 2015b. Primary immunodeficiencies associated with EBV disease. Curr. Top. Microbiol. Immunol. 390:241-265.
-
(2015)
Curr. Top. Microbiol. Immunol
, vol.390
, pp. 241-265
-
-
Cohen, J.I.1
-
28
-
-
34248659404
-
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
-
Comoli, P., S. Basso, M. Zecca, D. Pagliara, F. Baldanti, M.E. Bernardo, W. Barberi, A. Moretta, M. Labirio, M. Paulli, et al. 2007. Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am. J. Transplant. 7:1648-1655. http://dx.doi.org/10.1111/j.1600-6143.2007.01823.x
-
(2007)
Am. J. Transplant
, vol.7
, pp. 1648-1655
-
-
Comoli, P.1
Basso, S.2
Zecca, M.3
Pagliara, D.4
Baldanti, F.5
Bernardo, M.E.6
Barberi, W.7
Moretta, A.8
Labirio, M.9
Paulli, M.10
-
29
-
-
33746035693
-
A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis
-
Crawford, D.H., K.F. Macsween, C.D. Higgins, R. Thomas, K. McAulay, H. Williams, N. Harrison, S. Reid, M. Conacher, J. Douglas, and A.J. Swerdlow. 2006. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin. Infect. Dis. 43:276-282. http://dx.doi.org/10.1086/505400
-
(2006)
Clin. Infect. Dis
, vol.43
, pp. 276-282
-
-
Crawford, D.H.1
Macsween, K.F.2
Higgins, C.D.3
Thomas, R.4
McAulay, K.5
Williams, H.6
Harrison, N.7
Reid, S.8
Conacher, M.9
Douglas, J.10
Swerdlow, A.J.11
-
30
-
-
84925536233
-
Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease
-
Dhalla, F., S. Murray, R. Sadler, B. Chaigne-Delalande, T. Sadaoka, E. Soilleux, G. Uzel, J. Miller, G.P. Collins, C.S. Hatton, et al. 2015. Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease. J. Clin. Immunol. 35:112-118. http://dx.doi.org/10.1007/s10875-014-0116-2
-
(2015)
J. Clin. Immunol
, vol.35
, pp. 112-118
-
-
Dhalla, F.1
Murray, S.2
Sadler, R.3
Chaigne-Delalande, B.4
Sadaoka, T.5
Soilleux, E.6
Uzel, G.7
Miller, J.8
Collins, G.P.9
Hatton, C.S.10
-
31
-
-
84858683311
-
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
-
Doubrovina, E., B. Oflaz-Sozmen, S.E. Prockop, N.A. Kernan, S. Abramson, J. Teruya-Feldstein, C. Hedvat, J.F. Chou, G. Heller, J.N. Barker, et al. 2012. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood. 119:2644-2656. http://dx.doi.org/10.1182/blood-2011-08-371971
-
(2012)
Blood
, vol.119
, pp. 2644-2656
-
-
Doubrovina, E.1
Oflaz-Sozmen, B.2
Prockop, S.E.3
Kernan, N.A.4
Abramson, S.5
Teruya-Feldstein, J.6
Hedvat, C.7
Chou, J.F.8
Heller, G.9
Barker, J.N.10
-
32
-
-
19344372415
-
+ T cells against EBV-infected cells
-
+ T cells against EBV-infected cells. Blood. 105:4383-4389. http://dx.doi.org/10.1182/blood-2004-08-3269
-
(2005)
Blood
, vol.105
, pp. 4383-4389
-
-
Dupré, L.1
Andolfi, G.2
Tangye, S.G.3
Clementi, R.4
Locatelli, F.5
Aricò, M.6
Aiuti, A.7
Roncarolo, M.G.8
-
33
-
-
78149356369
-
X-linked lymphoproliferative syndromes: brothers or distant cousins?
-
Filipovich, A.H., K. Zhang, A.L. Snow, and R.A. Marsh. 2010. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 116:3398-3408. http://dx.doi.org/10.1182/blood-2010-03-275909
-
(2010)
Blood
, vol.116
, pp. 3398-3408
-
-
Filipovich, A.H.1
Zhang, K.2
Snow, A.L.3
Marsh, R.A.4
-
34
-
-
11844287671
-
Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands
-
Frangou, P., M. Buettner, and G. Niedobitek. 2005. Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands. J. Infect. Dis. 191:238-242. http://dx.doi.org/10.1086/426823
-
(2005)
J. Infect. Dis
, vol.191
, pp. 238-242
-
-
Frangou, P.1
Buettner, M.2
Niedobitek, G.3
-
35
-
-
34249909831
-
Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)
-
Garibyan, L., A.A. Lobito, R.M. Siegel, M.E. Call, K.W. Wucherpfennig, and R.S. Geha. 2007. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J. Clin. Invest. 117:1550-1557. http://dx.doi.org/10.1172/JCI31023
-
(2007)
J. Clin. Invest
, vol.117
, pp. 1550-1557
-
-
Garibyan, L.1
Lobito, A.A.2
Siegel, R.M.3
Call, M.E.4
Wucherpfennig, K.W.5
Geha, R.S.6
-
36
-
-
84912042007
-
Interleukin-2-inducible T-cell kinase (ITK) deficiency-clinical and molecular aspects
-
Ghosh, S., K. Bienemann, K. Boztug, and A. Borkhardt. 2014. Interleukin-2-inducible T-cell kinase (ITK) deficiency-clinical and molecular aspects. J. Clin. Immunol. 34:892-899. http://dx.doi.org/10.1007/s10875-014-0110-8
-
(2014)
J. Clin. Immunol
, vol.34
, pp. 892-899
-
-
Ghosh, S.1
Bienemann, K.2
Boztug, K.3
Borkhardt, A.4
-
37
-
-
0034733164
-
Signal transduction
-
Golstein, P. 2000. Signal transduction. FasL binds preassembled Fas. Science. 288:2328-2329. http://dx.doi.org/10.1126/science.288.5475.2328
-
(2000)
FasL binds preassembled Fas. Science
, vol.288
, pp. 2328-2329
-
-
Golstein, P.1
-
38
-
-
84874906669
-
Introduction: Infections in solid organ transplantation
-
Green, M. 2013. Introduction: Infections in solid organ transplantation. Am. J. Transplant. 13:3-8. http://dx.doi.org/10.1111/ajt.12093
-
(2013)
Am. J. Transplant
, vol.13
, pp. 3-8
-
-
Green, M.1
-
39
-
-
12944328008
-
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells
-
Gustafsson, A., V. Levitsky, J.Z. Zou, T. Frisan, T. Dalianis, P. Ljungman, O. Ringden, J. Winiarski, I. Ernberg, and M.G. Masucci. 2000. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood. 95:807-814.
-
(2000)
Blood
, vol.95
, pp. 807-814
-
-
Gustafsson, A.1
Levitsky, V.2
Zou, J.Z.3
Frisan, T.4
Dalianis, T.5
Ljungman, P.6
Ringden, O.7
Winiarski, J.8
Ernberg, I.9
Masucci, M.G.10
-
41
-
-
34548025068
-
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
-
Haque, T., G.M. Wilkie, M.M. Jones, C.D. Higgins, G. Urquhart, P. Wingate, D. Burns, K. McAulay, M. Turner, C. Bellamy, et al. 2007. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 110:1123-1131. http://dx.doi.org/10.1182/blood-2006-12-063008
-
(2007)
Blood
, vol.110
, pp. 1123-1131
-
-
Haque, T.1
Wilkie, G.M.2
Jones, M.M.3
Higgins, C.D.4
Urquhart, G.5
Wingate, P.6
Burns, D.7
McAulay, K.8
Turner, M.9
Bellamy, C.10
-
42
-
-
0036941104
-
Epstein-Barr virus replication in tongue epithelial cells
-
Herrmann, K., P. Frangou, J. Middeldorp, and G. Niedobitek. 2002. Epstein-Barr virus replication in tongue epithelial cells. J. Gen. Virol. 83:2995-2998. http://dx.doi.org/10.1099/0022-1317-83-12-2995
-
(2002)
J. Gen. Virol
, vol.83
, pp. 2995-2998
-
-
Herrmann, K.1
Frangou, P.2
Middeldorp, J.3
Niedobitek, G.4
-
43
-
-
77950394280
-
How I treat EBV lymphoproliferation
-
Heslop, H.E. 2009. How I treat EBV lymphoproliferation. Blood. 114:4002-4008. http://dx.doi.org/10.1182/blood-2009-07-143545
-
(2009)
Blood
, vol.114
, pp. 4002-4008
-
-
Heslop, H.E.1
-
44
-
-
0029924619
-
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of genemodified virus-specific T lymphocytes
-
Heslop, H.E., C.Y. Ng, C. Li, C.A. Smith, S.K. Loftin, R.A. Krance, M.K. Brenner, and C.M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of genemodified virus-specific T lymphocytes. Nat. Med. 2:551-555. http://dx.doi.org/10.1038/nm0596-551
-
(1996)
Nat. Med
, vol.2
, pp. 551-555
-
-
Heslop, H.E.1
Ng, C.Y.2
Li, C.3
Smith, C.A.4
Loftin, S.K.5
Krance, R.A.6
Brenner, M.K.7
Rooney, C.M.8
-
45
-
-
77649221824
-
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
-
Heslop, H.E., K.S. Slobod, M.A. Pule, G.A. Hale, A. Rousseau, C.A. Smith, C.M. Bollard, H. Liu, M.F. Wu, R.J. Rochester, et al. 2010. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 115:925-935. http://dx.doi.org/10.1182/blood-2009-08-239186
-
(2010)
Blood
, vol.115
, pp. 925-935
-
-
Heslop, H.E.1
Slobod, K.S.2
Pule, M.A.3
Hale, G.A.4
Rousseau, A.5
Smith, C.A.6
Bollard, C.M.7
Liu, H.8
Wu, M.F.9
Rochester, R.J.10
-
46
-
-
0028296046
-
Characterization of the human CD27 ligand, a novel member of the TNF gene family
-
Hintzen, R.Q., S.M. Lens, M.P. Beckmann, R.G. Goodwin, D. Lynch, and R.A. van Lier. 1994. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J. Immunol. 152:1762-1773.
-
(1994)
J. Immunol
, vol.152
, pp. 1762-1773
-
-
Hintzen, R.Q.1
Lens, S.M.2
Beckmann, M.P.3
Goodwin, R.G.4
Lynch, D.5
van Lier, R.A.6
-
47
-
-
34247872819
-
Cellular responses to viral infection in humans: lessons from Epstein-Barr virus
-
Hislop, A.D., G.S. Taylor, D. Sauce, and A.B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141553
-
(2007)
Annu. Rev. Immunol
, vol.25
, pp. 587-617
-
-
Hislop, A.D.1
Taylor, G.S.2
Sauce, D.3
Rickinson, A.B.4
-
48
-
-
78049368414
-
+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM familypositive B-cell targets
-
+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM familypositive B-cell targets. Blood. 116:3249-3257. http://dx.doi.org/10.1182/blood-2009-09-238832
-
(2010)
Blood
, vol.116
, pp. 3249-3257
-
-
Hislop, A.D.1
Palendira, U.2
Leese, A.M.3
Arkwright, P.D.4
Rohrlich, P.S.5
Tangye, S.G.6
Gaspar, H.B.7
Lankester, A.C.8
Moretta, A.9
Rickinson, A.B.10
-
49
-
-
66449085077
-
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
-
Huck, K., O. Feyen, T. Niehues, F. Rüschendorf, N. Hübner, H.J. Laws, T. Telieps, S. Knapp, H.H. Wacker, A. Meindl, et al. 2009. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J. Clin. Invest. 119:1350-1358. http://dx.doi.org/10.1172/JCI37901
-
(2009)
J. Clin. Invest
, vol.119
, pp. 1350-1358
-
-
Huck, K.1
Feyen, O.2
Niehues, T.3
Rüschendorf, F.4
Hübner, N.5
Laws, H.J.6
Telieps, T.7
Knapp, S.8
Wacker, H.H.9
Meindl, A.10
-
50
-
-
85008226660
-
The long and complicated relationship between Epstein-Barr virus and epithelial cells
-
Hutt-Fletcher, L.M. 2017. The long and complicated relationship between Epstein-Barr virus and epithelial cells. J. Virol. 91:e01677-16. http://dx.doi.org/10.1128/JVI.01677-16
-
(2017)
J. Virol
, vol.91
-
-
Hutt-Fletcher, L.M.1
-
51
-
-
85008474195
-
Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection
-
Izawa, K., E. Martin, C. Soudais, J. Bruneau, D. Boutboul, R. Rodriguez, C. Lenoir, A.D. Hislop, C. Besson, F. Touzot, et al. 2017. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J. Exp. Med. 214:73-89. http://dx.doi.org/10.1084/jem.20160784
-
(2017)
J. Exp. Med
, vol.214
, pp. 73-89
-
-
Izawa, K.1
Martin, E.2
Soudais, C.3
Bruneau, J.4
Boutboul, D.5
Rodriguez, R.6
Lenoir, C.7
Hislop, A.D.8
Besson, C.9
Touzot, F.10
-
52
-
-
0033849422
-
Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10
-
Jung, J., J. Choe, L. Li, and Y.S. Choi. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30:2437-2443. http://dx.doi.org/10.1002/1521-4141(2000)30:8<2437::AID-IMMU2437>3.0.CO;2-M
-
(2000)
Eur. J. Immunol
, vol.30
, pp. 2437-2443
-
-
Jung, J.1
Choe, J.2
Li, L.3
Choi, Y.S.4
-
53
-
-
13044295992
-
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
-
Khanna, R., S. Bell, M. Sherritt, A. Galbraith, S.R. Burrows, L. Rafter, B. Clarke, R. Slaughter, M.C. Falk, J. Douglass, et al. 1999. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc. Natl. Acad. Sci. USA. 96:10391-10396. http://dx.doi.org/10.1073/pnas.96.18.10391
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 10391-10396
-
-
Khanna, R.1
Bell, S.2
Sherritt, M.3
Galbraith, A.4
Burrows, S.R.5
Rafter, L.6
Clarke, B.7
Slaughter, R.8
Falk, M.C.9
Douglass, J.10
-
54
-
-
0034651548
-
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation
-
Kuehnle, I., M.H. Huls, Z. Liu, M. Semmelmann, R.A. Krance, M.K. Brenner, C.M. Rooney, and H.E. Heslop. 2000. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 95:1502-1505.
-
(2000)
Blood
, vol.95
, pp. 1502-1505
-
-
Kuehnle, I.1
Huls, M.H.2
Liu, Z.3
Semmelmann, M.4
Krance, R.A.5
Brenner, M.K.6
Rooney, C.M.7
Heslop, H.E.8
-
55
-
-
0142197627
-
B cells under influence: transformation of B cells by Epstein-Barr virus
-
Küppers, R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3:801-812. http://dx.doi.org/10.1038/nri1201
-
(2003)
Nat. Rev. Immunol
, vol.3
, pp. 801-812
-
-
Küppers, R.1
-
56
-
-
33645745240
-
Spectrum of Epstein-Barr virus-associated diseases
-
Kutok, J.L., and F. Wang. 2006. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1:375-404. http://dx.doi.org/10.1146/annurev.pathol.1.110304.100209
-
(2006)
Annu. Rev. Pathol
, vol.1
, pp. 375-404
-
-
Kutok, J.L.1
Wang, F.2
-
57
-
-
84971325230
-
Stepwise phosphorylation of p65 promotes NF-κB activation and NK cell responses during target cell recognition
-
Kwon, H.J., G.E. Choi, S. Ryu, S.J. Kwon, S.C. Kim, C. Booth, K.E. Nichols, and H.S. Kim. 2016. Stepwise phosphorylation of p65 promotes NF-κB activation and NK cell responses during target cell recognition. Nat. Commun. 7:11686. http://dx.doi.org/10.1038/ncomms11686
-
(2016)
Nat. Commun
, vol.7
, pp. 11686
-
-
Kwon, H.J.1
Choi, G.E.2
Ryu, S.3
Kwon, S.J.4
Kim, S.C.5
Booth, C.6
Nichols, K.E.7
Kim, H.S.8
-
58
-
-
84961879643
-
NKG2D receptor and its ligands in host defense
-
Lanier, L.L. 2015. NKG2D receptor and its ligands in host defense. Cancer Immunol. Res. 3:575-582. http://dx.doi.org/10.1158/2326-6066.CIR-15-0098
-
(2015)
Cancer Immunol. Res
, vol.3
, pp. 575-582
-
-
Lanier, L.L.1
-
59
-
-
0034892688
-
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
-
Leen, A., P. Meij, I. Redchenko, J. Middeldorp, E. Bloemena, A. Rickinson, and N. Blake. 2001. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses. J. Virol. 75:8649-8659. http://dx.doi.org/10.1128/JVI.75.18.8649-8659.2001
-
(2001)
J. Virol
, vol.75
, pp. 8649-8659
-
-
Leen, A.1
Meij, P.2
Redchenko, I.3
Middeldorp, J.4
Bloemena, E.5
Rickinson, A.6
Blake, N.7
-
60
-
-
0032392095
-
Control of lymphocyte function through CD27-CD70 interactions
-
Lens, S.M., K. Tesselaar, M.H. van Oers, and R.A. van Lier. 1998. Control of lymphocyte function through CD27-CD70 interactions. Semin. Immunol. 10:491-499. http://dx.doi.org/10.1006/smim.1998.0154
-
(1998)
Semin. Immunol
, vol.10
, pp. 491-499
-
-
Lens, S.M.1
Tesselaar, K.2
van Oers, M.H.3
van Lier, R.A.4
-
61
-
-
79960915373
-
2+ revealed by human T-cell immunodeficiency
-
2+ revealed by human T-cell immunodeficiency. Nature. 475:471-476. http://dx.doi.org/10.1038/nature10246
-
(2011)
Nature
, vol.475
, pp. 471-476
-
-
Li, F.Y.1
Chaigne-Delalande, B.2
Kanellopoulou, C.3
Davis, J.C.4
Matthews, H.F.5
Douek, D.C.6
Cohen, J.I.7
Uzel, G.8
Su, H.C.9
Lenardo, M.J.10
-
62
-
-
84860772152
-
Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBVassociated lymphoproliferative diseases
-
Linka, R.M., S.L. Risse, K. Bienemann, M. Werner, Y. Linka, F. Krux, C. Synaeve, R. Deenen, S. Ginzel, R. Dvorsky, et al. 2012. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBVassociated lymphoproliferative diseases. Leukemia. 26:963-971. http://dx.doi.org/10.1038/leu.2011.371
-
(2012)
Leukemia
, vol.26
, pp. 963-971
-
-
Linka, R.M.1
Risse, S.L.2
Bienemann, K.3
Werner, M.4
Linka, Y.5
Krux, F.6
Synaeve, C.7
Deenen, R.8
Ginzel, S.9
Dvorsky, R.10
-
63
-
-
20144389912
-
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
-
Long, H.M., T.A. Haigh, N.H. Gudgeon, A.M. Leen, C.W. Tsang, J. Brooks, E. Landais, E. Houssaint, S.P. Lee, A.B. Rickinson, and G.S. Taylor. 2005. CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J. Virol. 79:4896-4907. http://dx.doi.org/10.1128/JVI.79.8.4896-4907.2005
-
(2005)
J. Virol
, vol.79
, pp. 4896-4907
-
-
Long, H.M.1
Haigh, T.A.2
Gudgeon, N.H.3
Leen, A.M.4
Tsang, C.W.5
Brooks, J.6
Landais, E.7
Houssaint, E.8
Lee, S.P.9
Rickinson, A.B.10
Taylor, G.S.11
-
64
-
-
84879559682
-
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
-
Long, H.M., O.L. Chagoury, A.M. Leese, G.B. Ryan, E. James, L.T. Morton, R.J. Abbott, S. Sabbah, W. Kwok, and A.B. Rickinson. 2013. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J. Exp. Med. 210:933-949. http://dx.doi.org/10.1084/jem.20121437
-
(2013)
J. Exp. Med
, vol.210
, pp. 933-949
-
-
Long, H.M.1
Chagoury, O.L.2
Leese, A.M.3
Ryan, G.B.4
James, E.5
Morton, L.T.6
Abbott, R.J.7
Sabbah, S.8
Kwok, W.9
Rickinson, A.B.10
-
65
-
-
0032525146
-
Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation
-
Lucas, K.G., R.L. Burton, S.E. Zimmerman, J. Wang, K.G. Cornetta, K.A. Robertson, C.H. Lee, and D.J. Emanuel. 1998. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood. 91:3654-3661.
-
(1998)
Blood
, vol.91
, pp. 3654-3661
-
-
Lucas, K.G.1
Burton, R.L.2
Zimmerman, S.E.3
Wang, J.4
Cornetta, K.G.5
Robertson, K.A.6
Lee, C.H.7
Emanuel, D.J.8
-
66
-
-
84859400860
-
IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection
-
Mansouri, D., S.A. Mahdaviani, S. Khalilzadeh, S.A. Mohajerani, M. Hasanzad, S. Sadr, S.A. Nadji, S. Karimi, A. Droodinia, N. Rezaei, et al. 2012. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection. Int. Arch. Allergy Immunol. 158:418-422. http://dx.doi.org/10.1159/000333472
-
(2012)
Int. Arch. Allergy Immunol
, vol.158
, pp. 418-422
-
-
Mansouri, D.1
Mahdaviani, S.A.2
Khalilzadeh, S.3
Mohajerani, S.A.4
Hasanzad, M.5
Sadr, S.6
Nadji, S.A.7
Karimi, S.8
Droodinia, A.9
Rezaei, N.10
-
67
-
-
77956508441
-
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
-
Marsh, R.A., L. Madden, B.J. Kitchen, R. Mody, B. McClimon, M.B. Jordan, J.J. Bleesing, K. Zhang, and A.H. Filipovich. 2010. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 116:1079-1082. http://dx.doi.org/10.1182/blood-2010-01-256099
-
(2010)
Blood
, vol.116
, pp. 1079-1082
-
-
Marsh, R.A.1
Madden, L.2
Kitchen, B.J.3
Mody, R.4
McClimon, B.5
Jordan, M.B.6
Bleesing, J.J.7
Zhang, K.8
Filipovich, A.H.9
-
68
-
-
84855964475
-
The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection
-
Mautner, J., and G.W. Bornkamm. 2012. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection. Eur. J. Cell Biol. 91:31-35. http://dx.doi.org/10.1016/j.ejcb.2011.01.007
-
(2012)
Eur. J. Cell Biol
, vol.91
, pp. 31-35
-
-
Mautner, J.1
Bornkamm, G.W.2
-
69
-
-
11244283829
-
Cellular immunotherapy for viral infection after HSC transplantation
-
Moss, P., and A. Rickinson. 2005. Cellular immunotherapy for viral infection after HSC transplantation. Nat. Rev. Immunol. 5:9-20. http://dx.doi.org/10.1038/nri1526
-
(2005)
Nat. Rev. Immunol
, vol.5
, pp. 9-20
-
-
Moss, P.1
Rickinson, A.2
-
70
-
-
84959178137
-
Adoptive immunotherapy for primary immunodeficiency disorders with virusspecific T lymphocytes
-
Naik, S., S.K. Nicholas, C.A. Martinez, A.M. Leen, P.J. Hanley, S.M. Gottschalk, C.M. Rooney, I.C. Hanson, R.A. Krance, E.J. Shpall, et al. 2016. Adoptive immunotherapy for primary immunodeficiency disorders with virusspecific T lymphocytes. J. Allergy Clin. Immunol. 137:1498-1505.e1. http://dx.doi.org/10.1016/j.jaci.2015.12.1311
-
(2016)
J. Allergy Clin. Immunol
, vol.137
, pp. 1498.e1-1505.e1
-
-
Naik, S.1
Nicholas, S.K.2
Martinez, C.A.3
Leen, A.M.4
Hanley, P.J.5
Gottschalk, S.M.6
Rooney, C.M.7
Hanson, I.C.8
Krance, R.A.9
Shpall, E.J.10
-
71
-
-
0033729573
-
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
-
Nakajima, H., M. Cella, A. Bouchon, H.L. Grierson, J. Lewis, C.S. Duckett, J.I. Cohen, and M. Colonna. 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30:3309-3318. http://dx.doi.org/10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3
-
(2000)
Eur. J. Immunol
, vol.30
, pp. 3309-3318
-
-
Nakajima, H.1
Cella, M.2
Bouchon, A.3
Grierson, H.L.4
Lewis, J.5
Duckett, C.S.6
Cohen, J.I.7
Colonna, M.8
-
72
-
-
0036363305
-
Clinicopathologic characteristics of post-transplant lymphoproliferative disorders
-
Nalesnik, M.A. 2002. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res. 159:9-18. http://dx.doi.org/10.1007/978-3-642-56352-2 2
-
(2002)
Recent Results Cancer Res
, vol.159
, pp. 9-18
-
-
Nalesnik, M.A.1
-
73
-
-
13144278345
-
Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
-
Nichols, K.E., D.P. Harkin, S. Levitz, M. Krainer, K.A. Kolquist, C. Genovese, A. Bernard, M. Ferguson, L. Zuo, E. Snyder, et al. 1998. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA. 95:13765-13770. http://dx.doi.org/10.1073/pnas.95.23.13765
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 13765-13770
-
-
Nichols, K.E.1
Harkin, D.P.2
Levitz, S.3
Krainer, M.4
Kolquist, K.A.5
Genovese, C.6
Bernard, A.7
Ferguson, M.8
Zuo, L.9
Snyder, E.10
-
74
-
-
20144387328
-
Regulation of NKT cell development by SAP, the protein defective in XLP
-
Nichols, K.E., J. Hom, S.Y. Gong, A. Ganguly, C.S. Ma, J.L. Cannons, S.G. Tangye, P.L. Schwartzberg, G.A. Koretzky, and P.L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11:340-345. http://dx.doi.org/10.1038/nm1189
-
(2005)
Nat. Med
, vol.11
, pp. 340-345
-
-
Nichols, K.E.1
Hom, J.2
Gong, S.Y.3
Ganguly, A.4
Ma, C.S.5
Cannons, J.L.6
Tangye, S.G.7
Schwartzberg, P.L.8
Koretzky, G.A.9
Stein, P.L.10
-
75
-
-
80052463886
-
+ polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins
-
+ polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins. Immunology. 134:161-171. http://dx.doi.org/10.1111/j.1365-2567.2011.03476.x
-
(2011)
Immunology
, vol.134
, pp. 161-171
-
-
Ning, R.J.1
Xu, X.Q.2
Chan, K.H.3
Chiang, A.K.4
-
76
-
-
84939154723
-
Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
-
Okada, S., J.G. Markle, E.K. Deenick, F. Mele, D. Averbuch, M. Lagos, M. Alzahrani, S. Al-Muhsen, R. Halwani, C.S. Ma, et al. 2015. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 349:606-613. http://dx.doi.org/10.1126/science.aaa4282
-
(2015)
Science
, vol.349
, pp. 606-613
-
-
Okada, S.1
Markle, J.G.2
Deenick, E.K.3
Mele, F.4
Averbuch, D.5
Lagos, M.6
Alzahrani, M.7
Al-Muhsen, S.8
Halwani, R.9
Ma, C.S.10
-
77
-
-
84883232593
-
Natural killer cell deficiency
-
Orange, J.S. 2013. Natural killer cell deficiency. J. Allergy Clin. Immunol. 132:515-525. http://dx.doi.org/10.1016/j.jaci.2013.07.020
-
(2013)
J. Allergy Clin. Immunol
, vol.132
, pp. 515-525
-
-
Orange, J.S.1
-
78
-
-
81055126777
-
Major histocompatibility complex class II expression deficiency caused by a RFX ANK founder mutation: a survey of 35 patients
-
Ouederni, M., Q.B. Vincent, P. Frange, F. Touzot, S. Scerra, M. Bejaoui, A. Bousfiha, Y. Levy, B. Lisowska-Grospierre, D. Canioni, et al. 2011. Major histocompatibility complex class II expression deficiency caused by a RFX ANK founder mutation: a survey of 35 patients. Blood. 118:5108-5118. http://dx.doi.org/10.1182/blood-2011-05-352716
-
(2011)
Blood
, vol.118
, pp. 5108-5118
-
-
Ouederni, M.1
Vincent, Q.B.2
Frange, P.3
Touzot, F.4
Scerra, S.5
Bejaoui, M.6
Bousfiha, A.7
Levy, Y.8
Lisowska-Grospierre, B.9
Canioni, D.10
-
79
-
-
79551644967
-
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
-
Pachlopnik Schmid, J., D. Canioni, D. Moshous, F. Touzot, N. Mahlaoui, F. Hauck, H. Kanegane, E. Lopez-Granados, E. Mejstrikova, I. Pellier, et al. 2011. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 117:1522-1529. http://dx.doi.org/10.1182/blood-2010-07-298372
-
(2011)
Blood
, vol.117
, pp. 1522-1529
-
-
Pachlopnik Schmid, J.1
Canioni, D.2
Moshous, D.3
Touzot, F.4
Mahlaoui, N.5
Hauck, F.6
Kanegane, H.7
Lopez-Granados, E.8
Mejstrikova, E.9
Pellier, I.10
-
80
-
-
84949096575
-
Primary immunodeficiencies and the control of Epstein-Barr virus infection
-
Palendira, U., and A.B. Rickinson. 2015. Primary immunodeficiencies and the control of Epstein-Barr virus infection. Ann. N. Y. Acad. Sci. 1356:22-44. http://dx.doi.org/10.1111/nyas.12937
-
(2015)
Ann. N. Y. Acad. Sci
, vol.1356
, pp. 22-44
-
-
Palendira, U.1
Rickinson, A.B.2
-
81
-
-
82455175808
-
Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP
-
Palendira, U., C. Low, A. Chan, A.D. Hislop, E. Ho, T.G. Phan, E. Deenick, M.C. Cook, D.S. Riminton, S. Choo, et al. 2011. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 9:e1001187. http://dx.doi.org/10.1371/journal.pbio.1001187
-
(2011)
PLoS Biol
, vol.9
-
-
Palendira, U.1
Low, C.2
Chan, A.3
Hislop, A.D.4
Ho, E.5
Phan, T.G.6
Deenick, E.7
Cook, M.C.8
Riminton, D.S.9
Choo, S.10
-
82
-
-
84863794143
-
+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus
-
+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. J. Exp. Med. 209:913-924. http://dx.doi.org/10.1084/jem.20112391
-
(2012)
J. Exp. Med
, vol.209
, pp. 913-924
-
-
Palendira, U.1
Low, C.2
Bell, A.I.3
Ma, C.S.4
Abbott, R.J.5
Phan, T.G.6
Riminton, D.S.7
Choo, S.8
Smart, J.M.9
Lougaris, V.10
-
83
-
-
84943292383
-
Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus-associated acute infectious mononucleosis: Implication for immune dysregulation
-
Panikkar, A., C. Smith, A. Hislop, N. Tellam, V. Dasari, K.A. Hogquist, M. Wykes, D.J. Moss, A. Rickinson, H.H. Balfour Jr., and R. Khanna. 2015a. Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus-associated acute infectious mononucleosis: Implication for immune dysregulation. J. Infect. Dis. 212:1957-1961. http://dx.doi.org/10.1093/infdis/jiv340
-
(2015)
J. Infect. Dis
, vol.212
, pp. 1957-1961
-
-
Panikkar, A.1
Smith, C.2
Hislop, A.3
Tellam, N.4
Dasari, V.5
Hogquist, K.A.6
Wykes, M.7
Moss, D.J.8
Rickinson, A.9
Balfour, H.H.10
Khanna, R.11
-
84
-
-
84938907507
-
Impaired Epstein-Barr virus-specific neutralizing antibody response during acute infectious mononucleosis is coincident with global B-cell dysfunction
-
Panikkar, A., C. Smith, A. Hislop, N. Tellam, V. Dasari, K.A. Hogquist, M. Wykes, D.J. Moss, A. Rickinson, H.H. Balfour Jr., and R. Khanna. 2015b. Impaired Epstein-Barr virus-specific neutralizing antibody response during acute infectious mononucleosis is coincident with global B-cell dysfunction. J. Virol. 89:9137-9141. http://dx.doi.org/10.1128/JVI.01293-15
-
(2015)
J. Virol
, vol.89
, pp. 9137-9141
-
-
Panikkar, A.1
Smith, C.2
Hislop, A.3
Tellam, N.4
Dasari, V.5
Hogquist, K.A.6
Wykes, M.7
Moss, D.J.8
Rickinson, A.9
Balfour, H.H.10
Khanna, R.11
-
85
-
-
0034618065
-
X-linked lymphoproliferative disease
-
Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H.D. Ochs, H. Wolf, J.Y. Bonnefoy, R. Biassoni, et al. 2000. X-linked lymphoproliferative disease. J. Exp. Med. 192:337-346. http://dx.doi.org/10.1084/jem.192.3.337
-
(2000)
J. Exp. Med
, vol.192
, pp. 337-346
-
-
Parolini, S.1
Bottino, C.2
Falco, M.3
Augugliaro, R.4
Giliani, S.5
Franceschini, R.6
Ochs, H.D.7
Wolf, H.8
Bonnefoy, J.Y.9
Biassoni, R.10
-
86
-
-
84881628097
-
Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases
-
Parvaneh, N., A.H. Filipovich, and A. Borkhardt. 2013. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Br. J. Haematol. 162:573-586. http://dx.doi.org/10.1111/bjh.12422
-
(2013)
Br. J. Haematol
, vol.162
, pp. 573-586
-
-
Parvaneh, N.1
Filipovich, A.H.2
Borkhardt, A.3
-
87
-
-
15444374149
-
Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product
-
Pasquier, B., L. Yin, M.C. Fondanèche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201:695-701. http://dx.doi.org/10.1084/jem.20042432
-
(2005)
J. Exp. Med
, vol.201
, pp. 695-701
-
-
Pasquier, B.1
Yin, L.2
Fondanèche, M.C.3
Relouzat, F.4
Bloch-Queyrat, C.5
Lambert, N.6
Fischer, A.7
de Saint-Basile, G.8
Latour, S.9
-
88
-
-
84929463191
-
A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease
-
Patiroglu, T., H. Haluk Akar, K. Gilmour, E. Unal, M. Akif Ozdemir, S. Bibi, S. Burns, S.C. Chiang, H. Schlums, Y.T. Bryceson, and M. Karakukcu. 2015. A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease. Clin. Immunol. 159:58-62. http://dx.doi.org/10.1016/j.clim.2015.04.015
-
(2015)
Clin. Immunol
, vol.159
, pp. 58-62
-
-
Patiroglu, T.1
Haluk Akar, H.2
Gilmour, K.3
Unal, E.4
Akif Ozdemir, M.5
Bibi, S.6
Burns, S.7
Chiang, S.C.8
Schlums, H.9
Bryceson, Y.T.10
Karakukcu, M.11
-
89
-
-
84900447559
-
Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection
-
Petrara, M.R., R. Freguja, K. Gianesin, M. Zanchetta, and A. De Rossi. 2013. Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. Front. Microbiol. 4:311. http://dx.doi.org/10.3389/fmicb.2013.00311
-
(2013)
Front. Microbiol
, vol.4
, pp. 311
-
-
Petrara, M.R.1
Freguja, R.2
Gianesin, K.3
Zanchetta, M.4
De Rossi, A.5
-
90
-
-
84948581722
-
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015
-
Picard, C., W. Al-Herz, A. Bousfiha, J.L. Casanova, T. Chatila, M.E. Conley, C. Cunningham-Rundles, A. Etzioni, S.M. Holland, C. Klein, et al. 2015. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J. Clin. Immunol. 35:696-726. http://dx.doi.org/10.1007/s10875-015-0201-1
-
(2015)
J. Clin. Immunol
, vol.35
, pp. 696-726
-
-
Picard, C.1
Al-Herz, W.2
Bousfiha, A.3
Casanova, J.L.4
Chatila, T.5
Conley, M.E.6
Cunningham-Rundles, C.7
Etzioni, A.8
Holland, S.M.9
Klein, C.10
-
91
-
-
0016772146
-
Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children
-
Provisor, A.J., J.J. Iacuone, R.R. Chilcote, R.G. Neiburger, and F.G. Crussi. 1975. Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children. N. Engl. J. Med. 293:62-65. http://dx.doi.org/10.1056/NEJM197507102930202
-
(1975)
N. Engl. J. Med
, vol.293
, pp. 62-65
-
-
Provisor, A.J.1
Iacuone, J.J.2
Chilcote, R.R.3
Neiburger, R.G.4
Crussi, F.G.5
-
92
-
-
0016772968
-
X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)
-
Purtilo, D.T., J.P. Yang, C.K. Cassel, R. Harper, S.R. Stephenson, B.H. Landing, and G.F. Vawter. 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 305:935-941. http://dx.doi.org/10.1016/S0140-6736(75)92004-8
-
(1975)
Lancet
, vol.305
, pp. 935-941
-
-
Purtilo, D.T.1
Yang, J.P.2
Cassel, C.K.3
Harper, R.4
Stephenson, S.R.5
Landing, B.H.6
Vawter, G.F.7
-
93
-
-
61849110214
-
Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk
-
Readinger, J.A., K.L. Mueller, A.M. Venegas, R. Horai, and P.L. Schwartzberg. 2009. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. Immunol. Rev. 228:93-114. http://dx.doi.org/10.1111/j.1600-065X.2008.00757.x
-
(2009)
Immunol. Rev
, vol.228
, pp. 93-114
-
-
Readinger, J.A.1
Mueller, K.L.2
Venegas, A.M.3
Horai, R.4
Schwartzberg, P.L.5
-
94
-
-
84897438282
-
Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory
-
Rickinson, A.B., H.M. Long, U. Palendira, C. Münz, and A.D. Hislop. 2014. Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol. 35:159-169. http://dx.doi.org/10.1016/j.it.2014.01.003
-
(2014)
Trends Immunol
, vol.35
, pp. 159-169
-
-
Rickinson, A.B.1
Long, H.M.2
Palendira, U.3
Münz, C.4
Hislop, A.D.5
-
95
-
-
33750597717
-
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
-
Rigaud, S., M.C. Fondanèche, N. Lambert, B. Pasquier, V. Mateo, P. Soulas, L. Galicier, F. Le Deist, F. Rieux-Laucat, P. Revy, et al. 2006. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 444:110-114. http://dx.doi.org/10.1038/nature05257
-
(2006)
Nature
, vol.444
, pp. 110-114
-
-
Rigaud, S.1
Fondanèche, M.C.2
Lambert, N.3
Pasquier, B.4
Mateo, V.5
Soulas, P.6
Galicier, L.7
Le Deist, F.8
Rieux-Laucat, F.9
Revy, P.10
-
96
-
-
0028816546
-
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
-
Rooney, C.M., C.A. Smith, C.Y. Ng, S. Loftin, C. Li, R.A. Krance, M.K. Brenner, and H.E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:9-13. http://dx.doi.org/10.1016/S0140-6736(95)91150-2
-
(1995)
Lancet
, vol.345
, pp. 9-13
-
-
Rooney, C.M.1
Smith, C.A.2
Ng, C.Y.3
Loftin, S.4
Li, C.5
Krance, R.A.6
Brenner, M.K.7
Heslop, H.E.8
-
97
-
-
0032170108
-
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
-
Rooney, C.M., C.A. Smith, C.Y. Ng, S.K. Loftin, J.W. Sixbey, Y. Gan, D.K. Srivastava, L.C. Bowman, R.A. Krance, M.K. Brenner, and H.E. Heslop. 1998. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 92:1549-1555.
-
(1998)
Blood
, vol.92
, pp. 1549-1555
-
-
Rooney, C.M.1
Smith, C.A.2
Ng, C.Y.3
Loftin, S.K.4
Sixbey, J.W.5
Gan, Y.6
Srivastava, D.K.7
Bowman, L.C.8
Krance, R.A.9
Brenner, M.K.10
Heslop, H.E.11
-
98
-
-
76549087625
-
+ T cell immunity
-
+ T cell immunity. Microbes Infect. 12:173-181. http://dx.doi.org/10.1016/j.micinf.2009.12.001
-
(2010)
Microbes Infect
, vol.12
, pp. 173-181
-
-
Rowe, M.1
Zuo, J.2
-
99
-
-
84874537855
-
Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27
-
Salzer, E., S. Daschkey, S. Choo, M. Gombert, E. Santos-Valente, S. Ginzel, M. Schwendinger, O.A. Haas, G. Fritsch, W.F. Pickl, et al. 2013. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica. 98:473-478. http://dx.doi.org/10.3324/haematol.2012.068791
-
(2013)
Haematologica
, vol.98
, pp. 473-478
-
-
Salzer, E.1
Daschkey, S.2
Choo, S.3
Gombert, M.4
Santos-Valente, E.5
Ginzel, S.6
Schwendinger, M.7
Haas, O.A.8
Fritsch, G.9
Pickl, W.F.10
-
100
-
-
84992410702
-
RAS GRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics
-
Salzer, E., D. Cagdas, M. Hons, E.M. Mace, W. Garncarz, O.Y. Petronczki, R. Platzer, L. Pfajfer, I. Bilic, S.A. Ban, et al. 2016. RAS GRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nat. Immunol. 17:1352-1360. http://dx.doi.org/10.1038/ni.3575
-
(2016)
Nat. Immunol
, vol.17
, pp. 1352-1360
-
-
Salzer, E.1
Cagdas, D.2
Hons, M.3
Mace, E.M.4
Garncarz, W.5
Petronczki, O.Y.6
Platzer, R.7
Pfajfer, L.8
Bilic, I.9
Ban, S.A.10
-
101
-
-
20044361817
-
Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease
-
Savoldo, B., C.M. Rooney, R.E. Quiros-Tejeira, Y. Caldwell, H.J. Wagner, T. Lee, M.J. Finegold, G. Dotti, H.E. Heslop, and J.A. Goss. 2005. Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. Am. J. Transplant. 5:566-572. http://dx.doi.org/10.1111/j.1600-6143.2004.00693.x
-
(2005)
Am. J. Transplant
, vol.5
, pp. 566-572
-
-
Savoldo, B.1
Rooney, C.M.2
Quiros-Tejeira, R.E.3
Caldwell, Y.4
Wagner, H.J.5
Lee, T.6
Finegold, M.J.7
Dotti, G.8
Heslop, H.E.9
Goss, J.A.10
-
102
-
-
0032190081
-
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
-
Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M.G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:462-469. http://dx.doi.org/10.1038/26683
-
(1998)
Nature
, vol.395
, pp. 462-469
-
-
Sayos, J.1
Wu, C.2
Morra, M.3
Wang, N.4
Zhang, X.5
Allen, D.6
van Schaik, S.7
Notarangelo, L.8
Geha, R.9
Roncarolo, M.G.10
-
103
-
-
84989318857
-
Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans
-
Schipp, C., S. Nabhani, K. Bienemann, N. Simanovsky, S. Kfir-Erenfeld, N. Assayag-Asherie, P.T. Oommen, S. Revel-Vilk, A. Hönscheid, M. Gombert, et al. 2016. Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans. Haematologica. 101:e392-e396. http://dx.doi.org/10.3324/haematol.2016.145136
-
(2016)
Haematologica
, vol.101
, pp. e392-e396
-
-
Schipp, C.1
Nabhani, S.2
Bienemann, K.3
Simanovsky, N.4
Kfir-Erenfeld, S.5
Assayag-Asherie, N.6
Oommen, P.T.7
Revel-Vilk, S.8
Hönscheid, A.9
Gombert, M.10
-
104
-
-
84904872011
-
Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia
-
Serwas, N.K., D. Cagdas, S.A. Ban, K. Bienemann, E. Salzer, I. Tezcan, A. Borkhardt, O. Sanal, and K. Boztug. 2014. Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia. Blood. 124:655-657. http://dx.doi.org/10.1182/blood-2014-03-564930
-
(2014)
Blood
, vol.124
, pp. 655-657
-
-
Serwas, N.K.1
Cagdas, D.2
Ban, S.A.3
Bienemann, K.4
Salzer, E.5
Tezcan, I.6
Borkhardt, A.7
Sanal, O.8
Boztug, K.9
-
105
-
-
79958022405
-
Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cellmediated transfer infection
-
Shannon-Lowe, C., and M. Rowe. 2011. Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cellmediated transfer infection. PLoS Pathog. 7:e1001338. http://dx.doi.org/10.1371/journal.ppat.1001338
-
(2011)
PLoS Pathog
, vol.7
-
-
Shannon-Lowe, C.1
Rowe, M.2
-
106
-
-
0037910274
-
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy
-
Sherritt, M.A., M. Bharadwaj, J.M. Burrows, L.E. Morrison, S.L. Elliott, J.E. Davis, L.M. Kear, R.E. Slaughter, S.C. Bell, A.J. Galbraith, et al. 2003. Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation. 75:1556-1560. http://dx.doi.org/10.1097/01.TP.0000058745.02123.6F
-
(2003)
Transplantation
, vol.75
, pp. 1556-1560
-
-
Sherritt, M.A.1
Bharadwaj, M.2
Burrows, J.M.3
Morrison, L.E.4
Elliott, S.L.5
Davis, J.E.6
Kear, L.M.7
Slaughter, R.E.8
Bell, S.C.9
Galbraith, A.J.10
-
107
-
-
0034733584
-
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
-
Siegel, R.M., J.K. Frederiksen, D.A. Zacharias, F.K. Chan, M. Johnson, D. Lynch, R.Y. Tsien, and M.J. Lenardo. 2000. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science. 288:2354-2357. http://dx.doi.org/10.1126/science.288.5475.2354
-
(2000)
Science
, vol.288
, pp. 2354-2357
-
-
Siegel, R.M.1
Frederiksen, J.K.2
Zacharias, D.A.3
Chan, F.K.4
Johnson, M.5
Lynch, D.6
Tsien, R.Y.7
Lenardo, M.J.8
-
108
-
-
82555165254
-
Hematopoietic stem cell transplantation for primary immunodeficiency diseases
-
Slatter, M.A., and A.J. Cant. 2011. Hematopoietic stem cell transplantation for primary immunodeficiency diseases. Ann. N. Y. Acad. Sci. 1238:122-131. http://dx.doi.org/10.1111/j.1749-6632.2011.06243.x
-
(2011)
Ann. N. Y. Acad. Sci
, vol.1238
, pp. 122-131
-
-
Slatter, M.A.1
Cant, A.J.2
-
109
-
-
70349678683
-
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency
-
Snow, A.L., R.A. Marsh, S.M. Krummey, P. Roehrs, L.R. Young, K. Zhang, J. van Hoff, D. Dhar, K.E. Nichols, A.H. Filipovich, et al. 2009. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J. Clin. Invest. 119:2976-2989.
-
(2009)
J. Clin. Invest
, vol.119
, pp. 2976-2989
-
-
Snow, A.L.1
Marsh, R.A.2
Krummey, S.M.3
Roehrs, P.4
Young, L.R.5
Zhang, K.6
van Hoff, J.7
Dhar, D.8
Nichols, K.E.9
Filipovich, A.H.10
-
110
-
-
39149121505
-
Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
-
Sokal, E.M., K. Hoppenbrouwers, C. Vandermeulen, M. Moutschen, P. Léonard, A. Moreels, M. Haumont, A. Bollen, F. Smets, and M. Denis. 2007. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J. Infect. Dis. 196:1749-1753. http://dx.doi.org/10.1086/523813
-
(2007)
J. Infect. Dis
, vol.196
, pp. 1749-1753
-
-
Sokal, E.M.1
Hoppenbrouwers, K.2
Vandermeulen, C.3
Moutschen, M.4
Léonard, P.5
Moreels, A.6
Haumont, M.7
Bollen, A.8
Smets, F.9
Denis, M.10
-
111
-
-
84883228121
-
X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis
-
Speckmann, C., K. Lehmberg, M.H. Albert, R.B. Damgaard, M. Fritsch, M. Gyrd-Hansen, A. Rensing-Ehl, T. Vraetz, B. Grimbacher, U. Salzer, et al. 2013. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin. Immunol. 149:133-141. http://dx.doi.org/10.1016/j.clim.2013.07.004
-
(2013)
Clin. Immunol
, vol.149
, pp. 133-141
-
-
Speckmann, C.1
Lehmberg, K.2
Albert, M.H.3
Damgaard, R.B.4
Fritsch, M.5
Gyrd-Hansen, M.6
Rensing-Ehl, A.7
Vraetz, T.8
Grimbacher, B.9
Salzer, U.10
-
112
-
-
79952335915
-
IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach
-
Stepensky, P., M. Weintraub, A. Yanir, S. Revel-Vilk, F. Krux, K. Huck, R.M. Linka, A. Shaag, O. Elpeleg, A. Borkhardt, and I.B. Resnick. 2011. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica. 96:472-476. http://dx.doi.org/10.3324/haematol.2010.033910
-
(2011)
Haematologica
, vol.96
, pp. 472-476
-
-
Stepensky, P.1
Weintraub, M.2
Yanir, A.3
Revel-Vilk, S.4
Krux, F.5
Huck, K.6
Linka, R.M.7
Shaag, A.8
Elpeleg, O.9
Borkhardt, A.10
Resnick, I.B.11
-
113
-
-
40349084108
-
Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ
-
Strowig, T., F. Brilot, F. Arrey, G. Bougras, D. Thomas, W.A. Muller, and C. Münz. 2008. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ PLoS Pathog. 4:e27. http://dx.doi.org/10.1371/journal.ppat.0040027
-
(2008)
PLoS Pathog
, vol.4
-
-
Strowig, T.1
Brilot, F.2
Arrey, F.3
Bougras, G.4
Thomas, D.5
Muller, W.A.6
Münz, C.7
-
114
-
-
0019255923
-
Deficient natural killer cell activity in x-linked lymphoproliferative syndrome
-
Sullivan, J.L., K.S. Byron, F.E. Brewster, and D.T. Purtilo. 1980. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science. 210:543-545. http://dx.doi.org/10.1126/science.6158759
-
(1980)
Science
, vol.210
, pp. 543-545
-
-
Sullivan, J.L.1
Byron, K.S.2
Brewster, F.E.3
Purtilo, D.T.4
-
115
-
-
0034331249
-
Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease
-
Sumegi, J., D. Huang, A. Lanyi, J.D. Davis, T.A. Seemayer, A. Maeda, G. Klein, M. Seri, H. Wakiguchi, D.T. Purtilo, and T.G. Gross. 2000. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 96:3118-3125.
-
(2000)
Blood
, vol.96
, pp. 3118-3125
-
-
Sumegi, J.1
Huang, D.2
Lanyi, A.3
Davis, J.D.4
Seemayer, T.A.5
Maeda, A.6
Klein, G.7
Seri, M.8
Wakiguchi, H.9
Purtilo, D.T.10
Gross, T.G.11
-
116
-
-
84930898417
-
XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP
-
Tangye, S.G. 2014. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J. Clin. Immunol. 34:772-779. http://dx.doi.org/10.1007/s10875-014-0083-7
-
(2014)
J. Clin. Immunol
, vol.34
, pp. 772-779
-
-
Tangye, S.G.1
-
117
-
-
70249085594
-
Memory B cells: effectors of longlived immune responses
-
Tangye, S.G., and D.M. Tarlinton. 2009. Memory B cells: effectors of longlived immune responses. Eur. J. Immunol. 39:2065-2075. http://dx.doi.org/10.1002/eji.200939531
-
(2009)
Eur. J. Immunol
, vol.39
, pp. 2065-2075
-
-
Tangye, S.G.1
Tarlinton, D.M.2
-
118
-
-
0034664724
-
Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
-
Tangye, S.G., J.H. Phillips, L.L. Lanier, and K.E. Nichols. 2000. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165:2932-2936. http://dx.doi.org/10.4049/jimmunol.165.6.2932
-
(2000)
J. Immunol
, vol.165
, pp. 2932-2936
-
-
Tangye, S.G.1
Phillips, J.H.2
Lanier, L.L.3
Nichols, K.E.4
-
119
-
-
84927652740
-
The immunology of Epstein-Barr virus-induced disease
-
Taylor, G.S., H.M. Long, J.M. Brooks, A.B. Rickinson, and A.D. Hislop. 2015. The immunology of Epstein-Barr virus-induced disease. Annu. Rev. Immunol. 33:787-821. http://dx.doi.org/10.1146/annurev-immunol-032414-112326
-
(2015)
Annu. Rev. Immunol
, vol.33
, pp. 787-821
-
-
Taylor, G.S.1
Long, H.M.2
Brooks, J.M.3
Rickinson, A.B.4
Hislop, A.D.5
-
120
-
-
0031573077
-
Characterization of murine CD70, the ligand of the TNF receptor family member CD27
-
Tesselaar, K., L.A. Gravestein, G.M. van Schijndel, J. Borst, and R.A. van Lier. 1997. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159:4959-4965.
-
(1997)
J. Immunol
, vol.159
, pp. 4959-4965
-
-
Tesselaar, K.1
Gravestein, L.A.2
van Schijndel, G.M.3
Borst, J.4
van Lier, R.A.5
-
121
-
-
0037218413
-
Expression of the murine CD27 ligand CD70 in vitro and in vivo
-
Tesselaar, K., Y. Xiao, R. Arens, G.M. van Schijndel, D.H. Schuurhuis, R.E. Mebius, J. Borst, and R.A. van Lier. 2003. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170:33-40. http://dx.doi.org/10.4049/jimmunol.170.1.33
-
(2003)
J. Immunol
, vol.170
, pp. 33-40
-
-
Tesselaar, K.1
Xiao, Y.2
Arens, R.3
van Schijndel, G.M.4
Schuurhuis, D.H.5
Mebius, R.E.6
Borst, J.7
van Lier, R.A.8
-
123
-
-
0020181223
-
Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts
-
Thorley-Lawson, D.A., R.T. Schooley, A.K. Bhan, and L.M. Nadler. 1982. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell. 30:415-425. http://dx.doi.org/10.1016/0092-8674(82)90239-2
-
(1982)
Cell
, vol.30
, pp. 415-425
-
-
Thorley-Lawson, D.A.1
Schooley, R.T.2
Bhan, A.K.3
Nadler, L.M.4
-
124
-
-
0037097731
-
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
-
van Esser, J.W., H.G. Niesters, B. van der Holt, E. Meijer, A.D. Osterhaus, J.W. Gratama, L.F. Verdonck, B. Löwenberg, and J.J. Cornelissen. 2002. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood. 99:4364-4369. http://dx.doi.org/10.1182/blood.V99.12.4364
-
(2002)
Blood
, vol.99
, pp. 4364-4369
-
-
van Esser, J.W.1
Niesters, H.G.2
van der Holt, B.3
Meijer, E.4
Osterhaus, A.D.5
Gratama, J.W.6
Verdonck, L.F.7
Löwenberg, B.8
Cornelissen, J.J.9
-
125
-
-
84857800335
-
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia
-
van Montfrans, J.M., A.I. Hoepelman, S. Otto, M. van Gijn, L. van de Corput, R.A. de Weger, L. Monaco-Shawver, P.P. Banerjee, E.A. Sanders, C.M. Jol-van der Zijde, et al. 2012. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J. Allergy Clin. Immunol. 129:787-793.e6. http://dx.doi.org/10.1016/j.jaci.2011.11.013
-
(2012)
J. Allergy Clin. Immunol
, vol.129
, pp. 787.e6-793.e6
-
-
van Montfrans, J.M.1
Hoepelman, A.I.2
Otto, S.3
van Gijn, M.4
van de Corput, L.5
de Weger, R.A.6
Monaco-Shawver, L.7
Banerjee, P.P.8
Sanders, E.A.9
Jol-van der Zijde, C.M.10
-
126
-
-
84987619415
-
Evidence of innate lymphoid cell redundancy in humans
-
Vély, F., V. Barlogis, B. Vallentin, B. Neven, C. Piperoglou, M. Ebbo, T. Perchet, M. Petit, N. Yessaad, F. Touzot, et al. 2016. Evidence of innate lymphoid cell redundancy in humans. Nat. Immunol. 17:1291-1299. http://dx.doi.org/10.1038/ni.3553
-
(2016)
Nat. Immunol
, vol.17
, pp. 1291-1299
-
-
Vély, F.1
Barlogis, V.2
Vallentin, B.3
Neven, B.4
Piperoglou, C.5
Ebbo, M.6
Perchet, T.7
Petit, M.8
Yessaad, N.9
Touzot, F.10
-
127
-
-
44849125747
-
CD27 defines phenotypically and functionally different human NK cell subsets
-
Vossen, M.T., M. Matmati, K.M. Hertoghs, P.A. Baars, M.R. Gent, G. Leclercq, J. Hamann, T.W. Kuijpers, and R.A. van Lier. 2008. CD27 defines phenotypically and functionally different human NK cell subsets. J. Immunol. 180:3739-3745. http://dx.doi.org/10.4049/jimmunol.180.6.3739
-
(2008)
J. Immunol
, vol.180
, pp. 3739-3745
-
-
Vossen, M.T.1
Matmati, M.2
Hertoghs, K.M.3
Baars, P.A.4
Gent, M.R.5
Leclercq, G.6
Hamann, J.7
Kuijpers, T.W.8
van Lier, R.A.9
-
128
-
-
17644373015
-
The immune response to primary EBV infection: a role for natural killer cells
-
Williams, H., K. McAulay, K.F. Macsween, N.J. Gallacher, C.D. Higgins, N. Harrison, A.J. Swerdlow, and D.H. Crawford. 2005. The immune response to primary EBV infection: a role for natural killer cells. Br. J. Haematol. 129:266-274. http://dx.doi.org/10.1111/j.1365-2141.2005.05452.x
-
(2005)
Br. J. Haematol
, vol.129
, pp. 266-274
-
-
Williams, H.1
McAulay, K.2
Macsween, K.F.3
Gallacher, N.J.4
Higgins, C.D.5
Harrison, N.6
Swerdlow, A.J.7
Crawford, D.H.8
-
129
-
-
4944266319
-
Epstein-Barr virus: 40 years on
-
Young, L.S., and A.B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4:757-768. http://dx.doi.org/10.1038/nrc1452
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 757-768
-
-
Young, L.S.1
Rickinson, A.B.2
|